Psyllid ID: psy13496


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------25
MKKYSERSKKKTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGTDIFKFY
ccccccccccHHHHccHHHHHHcccccccccccHHHHHHHHHHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHHHccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHccccccHHHHHHHHcccccccccccccccccccccccccccc
ccccccccccEEEEcccEEEEcccccEcccHHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccEcccccEccccHHHHHHHHHHHHHHHHccHHHccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccHHHccHHHHHHHHHHHcHHHHHHHHHHHcccccHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHcHHHHHccccccccccccccccEEEEc
mkkyserskkktivdntsvlenhhwrsantsvlenhhwrSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLdsgsldlskaeDRHFILQIALKcadisnpcrpwdvskkWSQKVCEEFFrqgdyerqlnlpvtslcdrhstsipkiqtGFFKFVVSPLFEEWHRFLDTKlstsmmghlrgnqAKWEGFFKFVVSPLFEEWHRFLDTKlstsmmghlrgnqakwegtdifkfy
mkkyserskkktivdntsvlenHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFfrqgdyerqlNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLstsmmghlrgnqakwegtdifKFY
MKKYSERSKKKTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGTDIFKFY
****************TSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGTDIF***
*KKYSERSKKKTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKW********************************************KFY
**********KTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGTDIFKFY
*******SKKKTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMG*********EGTDIFKFY
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MKKYSERSKKKTIVDNTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGTDIFKFY
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query249 2.2.26 [Sep-21-2011]
Q13946482 High affinity cAMP-specif yes N/A 0.771 0.398 0.525 1e-55
P70453456 High affinity cAMP-specif yes N/A 0.771 0.421 0.525 1e-55
O08593426 High affinity cAMP-specif no N/A 0.771 0.450 0.525 4e-55
Q9NP56450 cAMP-specific 3',5'-cycli no N/A 0.742 0.411 0.534 3e-54
Q9QXQ1446 cAMP-specific 3',5'-cycli no N/A 0.742 0.414 0.534 3e-54
Q23917793 3',5'-cyclic-nucleotide p yes N/A 0.714 0.224 0.366 6e-26
Q08499809 cAMP-specific 3',5'-cycli no N/A 0.606 0.186 0.362 4e-25
Q01063747 cAMP-specific 3',5'-cycli no N/A 0.606 0.202 0.362 9e-25
P14270803 cAMP-specific 3',5'-cycli no N/A 0.606 0.188 0.362 1e-24
Q07343736 cAMP-specific 3',5'-cycli no N/A 0.734 0.248 0.305 1e-23
>sp|Q13946|PDE7A_HUMAN High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A OS=Homo sapiens GN=PDE7A PE=1 SV=2 Back     alignment and function desciption
 Score =  216 bits (550), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 103/196 (52%), Positives = 140/196 (71%), Gaps = 4/196 (2%)

Query: 14  VDNTSVLENHHWRSA---NTSVLENHHWRSAVGCLLESNVAEQLG-SIRPELEQQISSLI 69
           V+   +++ +H+ +    NTSVLENHHWRSAVG L ES +   L    R ++E QI +LI
Sbjct: 259 VNQPFLIKTNHYLATLYKNTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALI 318

Query: 70  LATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQ 129
           LATDI+RQ E+L+ F+++LD G L L     RH +LQ+ALKCADI NPCR W++SK+WS+
Sbjct: 319 LATDISRQNEYLSLFRSHLDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSE 378

Query: 130 KVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLST 189
           KV EEFF QGD E++ +L V+ LCDRH+ SI  IQ GF  ++V PLF EW RF +T+LS 
Sbjct: 379 KVTEEFFHQGDIEKKYHLGVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQ 438

Query: 190 SMMGHLRGNQAKWEGF 205
           +M+GH+  N+A W+G 
Sbjct: 439 TMLGHVGLNKASWKGL 454




Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May have a role in muscle signal transduction.
Homo sapiens (taxid: 9606)
EC: 3EC: .EC: 1EC: .EC: 4EC: .EC: 1EC: 7
>sp|P70453|PDE7A_MOUSE High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A OS=Mus musculus GN=Pde7a PE=2 SV=2 Back     alignment and function description
>sp|O08593|PDE7A_RAT High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A (Fragment) OS=Rattus norvegicus GN=Pde7a PE=2 SV=1 Back     alignment and function description
>sp|Q9NP56|PDE7B_HUMAN cAMP-specific 3',5'-cyclic phosphodiesterase 7B OS=Homo sapiens GN=PDE7B PE=1 SV=1 Back     alignment and function description
>sp|Q9QXQ1|PDE7B_MOUSE cAMP-specific 3',5'-cyclic phosphodiesterase 7B OS=Mus musculus GN=Pde7b PE=2 SV=1 Back     alignment and function description
>sp|Q23917|PDE2_DICDI 3',5'-cyclic-nucleotide phosphodiesterase regA OS=Dictyostelium discoideum GN=regA PE=1 SV=1 Back     alignment and function description
>sp|Q08499|PDE4D_HUMAN cAMP-specific 3',5'-cyclic phosphodiesterase 4D OS=Homo sapiens GN=PDE4D PE=1 SV=2 Back     alignment and function description
>sp|Q01063|PDE4D_MOUSE cAMP-specific 3',5'-cyclic phosphodiesterase 4D OS=Mus musculus GN=Pde4d PE=1 SV=2 Back     alignment and function description
>sp|P14270|PDE4D_RAT cAMP-specific 3',5'-cyclic phosphodiesterase 4D OS=Rattus norvegicus GN=Pde4d PE=1 SV=4 Back     alignment and function description
>sp|Q07343|PDE4B_HUMAN cAMP-specific 3',5'-cyclic phosphodiesterase 4B OS=Homo sapiens GN=PDE4B PE=1 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query249
312381624 1243 hypothetical protein AND_06013 [Anophele 0.702 0.140 0.8 7e-82
340715379 1182 PREDICTED: hypothetical protein LOC10064 0.767 0.161 0.708 1e-81
157136107 872 camp-specific 3,5-cyclic phosphodiestera 0.702 0.200 0.805 2e-81
328783208 1209 PREDICTED: hypothetical protein LOC41402 0.767 0.157 0.708 2e-81
380013365 1212 PREDICTED: uncharacterized protein LOC10 0.767 0.157 0.708 2e-81
350400022 1182 PREDICTED: hypothetical protein LOC10074 0.714 0.150 0.770 2e-81
170045624 821 c-AMP-specific 3',5'-cyclic phosphodiest 0.702 0.213 0.805 4e-81
383863568 1087 PREDICTED: uncharacterized protein LOC10 0.714 0.163 0.770 1e-80
345491937 1063 PREDICTED: hypothetical protein LOC10011 0.702 0.164 0.795 1e-80
158294334 934 AGAP005536-PA [Anopheles gambiae str. PE 0.702 0.187 0.788 8e-80
>gi|312381624|gb|EFR27332.1| hypothetical protein AND_06013 [Anopheles darlingi] Back     alignment and taxonomy information
 Score =  309 bits (791), Expect = 7e-82,   Method: Compositional matrix adjust.
 Identities = 140/175 (80%), Positives = 156/175 (89%)

Query: 29  NTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYL 88
           NTSVLENHHWRSA+GCLLES VAEQ+  IRPELE+QISSLILATDITRQQEF+ RF+ YL
Sbjct: 345 NTSVLENHHWRSAIGCLLESGVAEQVQDIRPELEKQISSLILATDITRQQEFIGRFRDYL 404

Query: 89  DSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLP 148
              +LD+   + RHFILQI+LKCADISNPCRPWD+SKKWSQKVCEEFFRQGDYERQLNLP
Sbjct: 405 SRDALDMRNTDHRHFILQISLKCADISNPCRPWDISKKWSQKVCEEFFRQGDYERQLNLP 464

Query: 149 VTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWE 203
           VTSLCDR +T++PKIQTGFFKFVV+PL +EWHRFL T LS SMM HLR NQA+WE
Sbjct: 465 VTSLCDRQTTTVPKIQTGFFKFVVTPLMDEWHRFLRTDLSHSMMHHLRYNQAQWE 519




Source: Anopheles darlingi

Species: Anopheles darlingi

Genus: Anopheles

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340715379|ref|XP_003396192.1| PREDICTED: hypothetical protein LOC100648320 [Bombus terrestris] Back     alignment and taxonomy information
>gi|157136107|ref|XP_001663656.1| camp-specific 3,5-cyclic phosphodiesterase [Aedes aegypti] gi|108870039|gb|EAT34264.1| AAEL013473-PA [Aedes aegypti] Back     alignment and taxonomy information
>gi|328783208|ref|XP_397457.4| PREDICTED: hypothetical protein LOC414021 [Apis mellifera] Back     alignment and taxonomy information
>gi|380013365|ref|XP_003690732.1| PREDICTED: uncharacterized protein LOC100869255 [Apis florea] Back     alignment and taxonomy information
>gi|350400022|ref|XP_003485709.1| PREDICTED: hypothetical protein LOC100748680 [Bombus impatiens] Back     alignment and taxonomy information
>gi|170045624|ref|XP_001850402.1| c-AMP-specific 3',5'-cyclic phosphodiesterase [Culex quinquefasciatus] gi|167868590|gb|EDS31973.1| c-AMP-specific 3',5'-cyclic phosphodiesterase [Culex quinquefasciatus] Back     alignment and taxonomy information
>gi|383863568|ref|XP_003707252.1| PREDICTED: uncharacterized protein LOC100877791 [Megachile rotundata] Back     alignment and taxonomy information
>gi|345491937|ref|XP_001599769.2| PREDICTED: hypothetical protein LOC100114896 [Nasonia vitripennis] Back     alignment and taxonomy information
>gi|158294334|ref|XP_315535.4| AGAP005536-PA [Anopheles gambiae str. PEST] gi|157015516|gb|EAA11823.5| AGAP005536-PA [Anopheles gambiae str. PEST] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query249
ZFIN|ZDB-GENE-031222-10505 pde7a "phosphodiesterase 7A" [ 0.759 0.374 0.533 1.1e-53
UNIPROTKB|F1NVY7424 PDE7B "Uncharacterized protein 0.722 0.424 0.554 8e-53
UNIPROTKB|E1BDB5457 LOC100849042 "Uncharacterized 0.767 0.417 0.528 1.3e-52
UNIPROTKB|Q13946482 PDE7A "High affinity cAMP-spec 0.767 0.396 0.528 1.3e-52
MGI|MGI:1202402456 Pde7a "phosphodiesterase 7A" [ 0.767 0.418 0.528 2.1e-52
UNIPROTKB|F1RTC1394 PDE7A "Uncharacterized protein 0.767 0.484 0.528 2.1e-52
UNIPROTKB|E2R487457 PDE7A "Uncharacterized protein 0.767 0.417 0.523 2.7e-52
RGD|621016446 Pde7b "phosphodiesterase 7B" [ 0.730 0.408 0.548 2.7e-52
UNIPROTKB|F1LN39395 Pde7b "Protein Pde7b" [Rattus 0.730 0.460 0.548 2.7e-52
UNIPROTKB|F1LSY3399 Pde7b "Protein Pde7b" [Rattus 0.730 0.456 0.548 2.7e-52
ZFIN|ZDB-GENE-031222-10 pde7a "phosphodiesterase 7A" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
 Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
 Identities = 103/193 (53%), Positives = 140/193 (72%)

Query:    14 VDNTSVLENHHWRSA---NTSVLENHHWRSAVGCLLESNVAEQLGSIRP-ELEQQISSLI 69
             V+   +++ +H+ +A   NTSVLENHHWRSAVG L E+ +   L +     +E+Q+ SLI
Sbjct:   276 VNQPFLIKTNHYLAALYRNTSVLENHHWRSAVGLLRETELFSHLPAEDSLSIERQLGSLI 335

Query:    70 LATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQ 129
             LATDI+RQ E+L+RF+ +LD   L+L  A  RHF+LQ+ALKCADI NPCRPW++SK+WS+
Sbjct:   336 LATDISRQNEYLSRFRTHLDENDLNLGNASHRHFVLQMALKCADICNPCRPWELSKQWSE 395

Query:   130 KVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLST 189
             KV EEFF QGD E++L L ++ LCD  + +I  +Q GF  +VV PLF EW RF DT+LS 
Sbjct:   396 KVTEEFFHQGDIEKKLKLEISPLCDSEANTIASVQIGFMTYVVEPLFAEWARFSDTRLSQ 455

Query:   190 SMMGHLRGNQAKW 202
             +M+GHL  N+A W
Sbjct:   456 TMLGHLGLNKASW 468


GO:0003824 "catalytic activity" evidence=IEA
GO:0008081 "phosphoric diester hydrolase activity" evidence=IEA
GO:0004114 "3',5'-cyclic-nucleotide phosphodiesterase activity" evidence=IEA
GO:0007165 "signal transduction" evidence=IEA
GO:0016787 "hydrolase activity" evidence=IEA
GO:0046872 "metal ion binding" evidence=IEA
UNIPROTKB|F1NVY7 PDE7B "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|E1BDB5 LOC100849042 "Uncharacterized protein" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|Q13946 PDE7A "High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
MGI|MGI:1202402 Pde7a "phosphodiesterase 7A" [Mus musculus (taxid:10090)] Back     alignment and assigned GO terms
UNIPROTKB|F1RTC1 PDE7A "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
UNIPROTKB|E2R487 PDE7A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
RGD|621016 Pde7b "phosphodiesterase 7B" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|F1LN39 Pde7b "Protein Pde7b" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms
UNIPROTKB|F1LSY3 Pde7b "Protein Pde7b" [Rattus norvegicus (taxid:10116)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

ID ?Name ?Annotated EC number ?Identity ?Query coverage ?Hit coverage ?RBH(Q2H) ?RBH(H2Q) ?
Q13946PDE7A_HUMAN3, ., 1, ., 4, ., 1, 70.52550.77100.3983yesN/A
P70453PDE7A_MOUSE3, ., 1, ., 4, ., 1, 70.52550.77100.4210yesN/A

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
3rd Layer3.1.4.17LOW CONFIDENCE prediction!
3rd Layer3.1.4LOW CONFIDENCE prediction!

Prediction of Functionally Associated Proteins


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query249
pfam00233237 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosph 1e-33
>gnl|CDD|109297 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosphodiesterase Back     alignment and domain information
 Score =  121 bits (304), Expect = 1e-33
 Identities = 52/184 (28%), Positives = 96/184 (52%), Gaps = 13/184 (7%)

Query: 16  NTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDIT 75
           + SVLENHH  +    +L++         + ++   +   ++R      +  +ILATD++
Sbjct: 67  DESVLENHH-LAQAFKLLQDEECN-----IFQNLSKKDFQTLR----DLVIEMILATDMS 116

Query: 76  RQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEF 135
              + L   K  ++         + +  +L + +  AD+SNP +PW + ++W++ + EEF
Sbjct: 117 LHFQKLKDLKTMVEQKKRLD--LDHKILLLSLLMHAADLSNPTKPWKLHRRWAELIMEEF 174

Query: 136 FRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHL 195
           F QGD ER+L LP + +CDR S  +PK Q GF  F+V P+F+     ++ K    ++  +
Sbjct: 175 FDQGDLERELGLPPSPMCDRTSAYVPKSQVGFIDFIVEPIFKLLADVVE-KDIQPLLDTI 233

Query: 196 RGNQ 199
             N+
Sbjct: 234 EDNR 237


Length = 237

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 249
KOG3689|consensus707 100.0
PF00233237 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase 100.0
KOG3688|consensus554 100.0
KOG1229|consensus775 100.0
>KOG3689|consensus Back     alignment and domain information
Probab=100.00  E-value=1.8e-54  Score=424.61  Aligned_cols=194  Identities=30%  Similarity=0.605  Sum_probs=185.0

Q ss_pred             ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC--ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHHH
Q psy13496         14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES--NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKAY   87 (249)
Q Consensus        14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~--~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~~   87 (249)
                      |||.|++.   .||.+|||.|||||||+++++.||+++  +|+.+++ .++..++++|+++|||||||+|++.++.|++.
T Consensus       478 tNN~f~iks~s~LA~lY~~~SvLE~HH~~~~~~lLqe~~~nIfsnLs~~~~~~~~~~i~~~ILATDla~h~~~~~~lk~~  557 (707)
T KOG3689|consen  478 TNNSYLIKSNSPLAQLYNDSSVLENHHFAQAFKLLQEEGCNIFSNLSKKQYQQIRKLIIDAILATDLALHFKKRADLKEM  557 (707)
T ss_pred             CCcHHHHhcCCHHHHHhCCccHHHHHHHHHHHHHHhccccchhhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            78999876   789999999999999999999999986  7888888 57899999999999999999999999999999


Q ss_pred             hhc-CCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccchhh
Q psy13496         88 LDS-GSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTG  166 (249)
Q Consensus        88 ~~~-~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~Qig  166 (249)
                      ++. +.+++.+.+||.++++++||||||||+||||+++++|+++|++|||.|||+|+++|++|+|||||++..+|++|+|
T Consensus       558 v~~~~~~~~~~~~hr~lvl~mmmtacDLSn~TKpwei~~qwa~~I~~EFf~QGDeek~lg~~p~pmmDR~k~~vp~~Qvg  637 (707)
T KOG3689|consen  558 VETKGVYDLENYSHRILVLAMMMTACDLSNPTKPWEIQKQWAELIAEEFFDQGDEEKELGLEPSPMMDRDKASVPKLQVG  637 (707)
T ss_pred             HhccCcccccchhHHHHHHHHHHHHhhccCCcCCccHHHHHHHHHHHHHHhcchHHHHcCCCCCcccccCcccCchhhhh
Confidence            988 7899999999999999999999999999999999999999999999999999999999999999999889999999


Q ss_pred             hHhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhhh
Q psy13496        167 FFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFV  209 (249)
Q Consensus       167 Fi~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~~  209 (249)
                      ||++||.|+|++|++++|+  .+++++.|+.|+.+|+++.+..
T Consensus       638 Fid~I~~Plyet~a~l~~~--~~pmld~l~~Nr~~w~~l~~~~  678 (707)
T KOG3689|consen  638 FIDYICIPLYETWADLVPD--AQPMLDGLEDNREWWQSLIPES  678 (707)
T ss_pred             HHHHHHHHHHHHHHHhccc--hhhHHHHHHHhHHHHHHhhhhh
Confidence            9999999999999999976  3789999999999999999876



>PF00233 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase; InterPro: IPR002073 The cyclic nucleotide phosphodiesterases (PDE) comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP Back     alignment and domain information
>KOG3688|consensus Back     alignment and domain information
>KOG1229|consensus Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query249
1zkl_A353 Multiple Determinants For Inhibitor Selectivity Of 1e-56
3g3n_A318 Pde7a Catalytic Domain In Complex With 3-(2,6- Difl 1e-56
3iad_A377 Crystal Structure Of Human Phosphodiesterase 4d Wit 4e-27
3g4g_A421 Crystal Structure Of Human Phosphodiesterase 4d Wit 9e-27
1tb7_A332 Catalytic Domain Of Human Phosphodiesterase 4d In C 9e-27
1xom_A349 Catalytic Domain Of Human Phosphodiesterase 4d In C 1e-26
1zkn_A334 Structure Of Pde4d2-Ibmx Length = 334 1e-26
2qyn_A328 Crystal Structure Of Pde4d2 In Complex With Inhibit 1e-26
2pw3_A327 Structure Of The Pde4d-Camp Complex Length = 327 1e-26
2fm0_A361 Crystal Structure Of Pde4d In Complex With L-869298 2e-26
3g4i_A381 Crystal Structure Of Human Phosphodiesterase 4d Wit 2e-26
3sl5_A359 Crystal Structure Of The Catalytic Domain Of Pde4d2 2e-26
1q9m_A360 Three Dimensional Structures Of Pde4d In Complex Wi 2e-26
1mkd_A328 Crystal Structure Of Pde4d Catalytic Domain And Zar 1e-25
3i8v_A354 Crystal Structure Of Human Pde4a With 4-(3-butoxy-4 4e-25
3tvx_A338 The Structure Of Pde4a With Pentoxifylline At 2.84a 5e-25
2qyk_A335 Crystal Structure Of Pde4a10 In Complex With Inhibi 5e-25
3d3p_A353 Crystal Structure Of Pde4b Catalytic Domain In Comp 9e-25
1xlx_A398 Catalytic Domain Of Human Phosphodiesterase 4b In C 1e-24
3hmv_A378 Catalytic Domain Of Human Phosphodiesterase 4b2b In 1e-24
3kkt_A398 Crystal Structure Of Human Pde4b With 5-[3-[(1s,2s, 1e-24
1xlz_A398 Catalytic Domain Of Human Phosphodiesterase 4b In C 1e-24
1tb5_A381 Catalytic Domain Of Human Phosphodiesterase 4b In C 1e-24
1ro6_A378 Crystal Structure Of Pde4b2b Complexed With Rolipra 1e-24
1f0j_A377 Catalytic Domain Of Human Phosphodiesterase 4b2b Le 1e-24
3g45_A421 Crystal Structure Of Human Phosphodiesterase 4b Wit 4e-24
2qym_A358 Crystal Structure Of Unliganded Pde4c2 Length = 358 4e-24
3o0j_A323 Pde4b In Complex With Ligand An2898 Length = 323 5e-24
3ly2_A357 Catalytic Domain Of Human Phosphodiesterase 4b In C 5e-24
2qyl_A337 Crystal Structure Of Pde4b2b In Complex With Inhibi 5e-24
1xm6_A398 Catalytic Domain Of Human Phosphodiesterase 4b In C 2e-23
1xm4_A398 Catalytic Domain Of Human Phosphodiesterase 4b In C 2e-23
3ecm_A338 Crystal Structure Of The Unliganded Pde8a Catalytic 5e-22
3n3z_A326 Crystal Structure Of Pde9a (E406a) Mutant In Comple 8e-21
2yy2_A333 Crystal Structure Of The Human Phosphodiesterase 9a 8e-21
3dy8_A329 Human Phosphodiesterase 9 In Complex With Product 5 9e-21
2hd1_A326 Crystal Structure Of Pde9 In Complex With Ibmx Leng 1e-20
3qi3_A533 Crystal Structure Of Pde9a(Q453e) In Complex With I 3e-20
1so2_A420 Catalytic Domain Of Human Phosphodiesterase 3b In C 8e-19
1taz_A365 Catalytic Domain Of Human Phosphodiesterase 1b Leng 1e-18
2r8q_A359 Structure Of Lmjpdeb1 In Complex With Ibmx Length = 2e-16
3hc8_A324 Investigation Of Aminopyridiopyrazinones As Pde5 In 6e-11
2chm_A326 Crystal Structure Of N2 Substituted Pyrazolo Pyrimi 6e-11
1t9s_A347 Catalytic Domain Of Human Phosphodiesterase 5a In C 1e-10
1xoz_A364 Catalytic Domain Of Human Phosphodiesterase 5a In C 1e-10
1rkp_A326 Crystal Structure Of Pde5a1-Ibmx Length = 326 2e-10
3b2r_A330 Crystal Structure Of Pde5a1 Catalytic Domain In Com 3e-10
1udt_A324 Crystal Structure Of Human Phosphodiesterase 5 Comp 3e-10
2h40_A326 Crystal Structure Of The Catalytic Domain Of Unliga 3e-10
3shy_A347 Crystal Structure Of The Pde5a1 Catalytic Domain In 3e-10
3itm_A345 Catalytic Domain Of Hpde2a Length = 345 4e-10
1z1l_A345 The Crystal Structure Of The Phosphodiesterase 2a C 4e-10
1t9r_A366 Catalytic Domain Of Human Phosphodiesterase 5a Leng 4e-10
3v93_A345 Unliganded Structure Of Tcrpdec1 Catalytic Domain L 4e-10
3bjc_A878 Crystal Structure Of The Pde5a Catalytic Domain In 5e-10
3jwq_A330 Crystal Structure Of Chimeric Pde5/pde6 Catalytic D 6e-10
4ddl_A338 Pde10a Crystal Structure Complexed With Novel Inhib 1e-09
2wey_A343 Human Pde-Papaverine Complex Obtained By Ligand Soa 1e-09
3ui7_A333 Discovery Of Orally Active Pyrazoloquinoline As A P 1e-09
2y0j_A340 Triazoloquinazolines As A Novel Class Of Phosphodie 1e-09
4ael_A344 Pde10a In Complex With The Inhibitor Az5 Length = 3 1e-09
4heu_A318 Crystal Structure Of Pde10a With A Biaryl Ether Inh 1e-09
4dff_A352 The Sar Development Of Dihydroimidazoisoquinoline D 1e-09
2oun_A331 Crystal Structure Of Pde10a2 In Complex With Amp Le 1e-09
3sn7_A345 Highly Potent, Selective, And Orally Active Phospho 1e-09
2ouv_A331 Crystal Structure Of Pde10a2 Mutant Of D564n Length 1e-09
3uuo_A337 The Discovery Of Potent, Selectivity, And Orally Bi 1e-09
3ibj_A691 X-Ray Structure Of Pde2a Length = 691 2e-09
3hqw_A376 Discovery Of Novel Inhibitors Of Pde10a Length = 37 4e-09
3hqy_A380 Discovery Of Novel Inhibitors Of Pde10a Length = 38 4e-09
2o8h_A362 Crystal Structure Of The Catalytic Domain Of Rat Ph 4e-09
3lxg_A308 Crystal Structure Of Rat Phosphodiesterase 10a In C 5e-09
2our_A331 Crystal Structure Of Pde10a2 Mutant D674a In Comple 1e-08
>pdb|1ZKL|A Chain A, Multiple Determinants For Inhibitor Selectivity Of Cyclic Nucleotide Phosphodiesterases Length = 353 Back     alignment and structure

Iteration: 1

Score = 216 bits (550), Expect = 1e-56, Method: Compositional matrix adjust. Identities = 101/178 (56%), Positives = 131/178 (73%), Gaps = 1/178 (0%) Query: 29 NTSVLENHHWRSAVGCLLESNVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKAY 87 NTSVLENHHWRSAVG L ES + L R ++E QI +LILATDI+RQ E+L+ F+++ Sbjct: 148 NTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSH 207 Query: 88 LDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNL 147 LD G L L RH +LQ+ALKCADI NPCR W++SK+WS+KV EEFF QGD E++ +L Sbjct: 208 LDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHL 267 Query: 148 PVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGF 205 V+ LCDRH+ SI IQ GF ++V PLF EW RF +T+LS +M+GH+ N+A W+G Sbjct: 268 GVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWKGL 325
>pdb|3G3N|A Chain A, Pde7a Catalytic Domain In Complex With 3-(2,6- Difluorophenyl)-2-(Methylthio)quinazolin-4(3h)-One Length = 318 Back     alignment and structure
>pdb|3IAD|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With Bound Allosteric Modulator Length = 377 Back     alignment and structure
>pdb|3G4G|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With Regulatory Domain And D155871 Length = 421 Back     alignment and structure
>pdb|1TB7|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4d In Complex With Amp Length = 332 Back     alignment and structure
>pdb|1XOM|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4d In Complex With Cilomilast Length = 349 Back     alignment and structure
>pdb|1ZKN|A Chain A, Structure Of Pde4d2-Ibmx Length = 334 Back     alignment and structure
>pdb|2QYN|A Chain A, Crystal Structure Of Pde4d2 In Complex With Inhibitor Npv Length = 328 Back     alignment and structure
>pdb|2PW3|A Chain A, Structure Of The Pde4d-Camp Complex Length = 327 Back     alignment and structure
>pdb|2FM0|A Chain A, Crystal Structure Of Pde4d In Complex With L-869298 Length = 361 Back     alignment and structure
>pdb|3G4I|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With D155871 Length = 381 Back     alignment and structure
>pdb|3SL5|A Chain A, Crystal Structure Of The Catalytic Domain Of Pde4d2 Complexed With Compound 10d Length = 359 Back     alignment and structure
>pdb|1Q9M|A Chain A, Three Dimensional Structures Of Pde4d In Complex With Roliprams And Implication On Inhibitor Selectivity Length = 360 Back     alignment and structure
>pdb|1MKD|A Chain A, Crystal Structure Of Pde4d Catalytic Domain And Zardaverine Complex Length = 328 Back     alignment and structure
>pdb|3I8V|A Chain A, Crystal Structure Of Human Pde4a With 4-(3-butoxy-4-methoxyphenyl) Methyl-2-imidazolidone Length = 354 Back     alignment and structure
>pdb|3TVX|A Chain A, The Structure Of Pde4a With Pentoxifylline At 2.84a Resolution Length = 338 Back     alignment and structure
>pdb|2QYK|A Chain A, Crystal Structure Of Pde4a10 In Complex With Inhibitor Npv Length = 335 Back     alignment and structure
>pdb|3D3P|A Chain A, Crystal Structure Of Pde4b Catalytic Domain In Complex With A Pyrazolopyridine Inhibitor Length = 353 Back     alignment and structure
>pdb|1XLX|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Cilomilast Length = 398 Back     alignment and structure
>pdb|3HMV|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b2b In Complex Tetrahydrobenzothiophene Inhibitor Length = 378 Back     alignment and structure
>pdb|3KKT|A Chain A, Crystal Structure Of Human Pde4b With 5-[3-[(1s,2s,4r)- Bicyclo[2.2.1]hept-2-Yloxy]-4-Methoxyp Henyl]tetrahydro-2(1h)- Pyrimidinone Reveals Ordering Of The C-Terminal Helix Residues 502- 509. Length = 398 Back     alignment and structure
>pdb|1XLZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Filaminast Length = 398 Back     alignment and structure
>pdb|1TB5|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Amp Length = 381 Back     alignment and structure
>pdb|1RO6|A Chain A, Crystal Structure Of Pde4b2b Complexed With Rolipram (r & S) Length = 378 Back     alignment and structure
>pdb|1F0J|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b2b Length = 377 Back     alignment and structure
>pdb|3G45|A Chain A, Crystal Structure Of Human Phosphodiesterase 4b With Regulatory Domain And D155988 Length = 421 Back     alignment and structure
>pdb|2QYM|A Chain A, Crystal Structure Of Unliganded Pde4c2 Length = 358 Back     alignment and structure
>pdb|3O0J|A Chain A, Pde4b In Complex With Ligand An2898 Length = 323 Back     alignment and structure
>pdb|3LY2|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex Wi Coumarin-Based Inhibitor Length = 357 Back     alignment and structure
>pdb|2QYL|A Chain A, Crystal Structure Of Pde4b2b In Complex With Inhibitor Npv Length = 337 Back     alignment and structure
>pdb|1XM6|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With (R)- Mesopram Length = 398 Back     alignment and structure
>pdb|1XM4|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Piclamilast Length = 398 Back     alignment and structure
>pdb|3ECM|A Chain A, Crystal Structure Of The Unliganded Pde8a Catalytic Domain Length = 338 Back     alignment and structure
>pdb|3N3Z|A Chain A, Crystal Structure Of Pde9a (E406a) Mutant In Complex With Ibmx Length = 326 Back     alignment and structure
>pdb|2YY2|A Chain A, Crystal Structure Of The Human Phosphodiesterase 9a Catalytic Domain Complexed With Ibmx Length = 333 Back     alignment and structure
>pdb|3DY8|A Chain A, Human Phosphodiesterase 9 In Complex With Product 5'-gmp (e+p Complex) Length = 329 Back     alignment and structure
>pdb|2HD1|A Chain A, Crystal Structure Of Pde9 In Complex With Ibmx Length = 326 Back     alignment and structure
>pdb|3QI3|A Chain A, Crystal Structure Of Pde9a(Q453e) In Complex With Inhibitor Bay73-6691 Length = 533 Back     alignment and structure
>pdb|1SO2|A Chain A, Catalytic Domain Of Human Phosphodiesterase 3b In Complex With A Dihydropyridazine Inhibitor Length = 420 Back     alignment and structure
>pdb|1TAZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 1b Length = 365 Back     alignment and structure
>pdb|2R8Q|A Chain A, Structure Of Lmjpdeb1 In Complex With Ibmx Length = 359 Back     alignment and structure
>pdb|3HC8|A Chain A, Investigation Of Aminopyridiopyrazinones As Pde5 Inhibitors: Evaluation Of Modifications To The Central Ring System. Length = 324 Back     alignment and structure
>pdb|2CHM|A Chain A, Crystal Structure Of N2 Substituted Pyrazolo Pyrimidinones- A Flipped Binding Mode In Pde5 Length = 326 Back     alignment and structure
>pdb|1T9S|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Gmp Length = 347 Back     alignment and structure
>pdb|1XOZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Tadalafil Length = 364 Back     alignment and structure
>pdb|1RKP|A Chain A, Crystal Structure Of Pde5a1-Ibmx Length = 326 Back     alignment and structure
>pdb|3B2R|A Chain A, Crystal Structure Of Pde5a1 Catalytic Domain In Complex With Vardenafil Length = 330 Back     alignment and structure
>pdb|1UDT|A Chain A, Crystal Structure Of Human Phosphodiesterase 5 Complexed With Sildenafil(Viagra) Length = 324 Back     alignment and structure
>pdb|2H40|A Chain A, Crystal Structure Of The Catalytic Domain Of Unliganded Pde5 Length = 326 Back     alignment and structure
>pdb|3SHY|A Chain A, Crystal Structure Of The Pde5a1 Catalytic Domain In Complex With Novel Inhibitors Length = 347 Back     alignment and structure
>pdb|3ITM|A Chain A, Catalytic Domain Of Hpde2a Length = 345 Back     alignment and structure
>pdb|1Z1L|A Chain A, The Crystal Structure Of The Phosphodiesterase 2a Catalytic Domain Length = 345 Back     alignment and structure
>pdb|1T9R|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a Length = 366 Back     alignment and structure
>pdb|3V93|A Chain A, Unliganded Structure Of Tcrpdec1 Catalytic Domain Length = 345 Back     alignment and structure
>pdb|3BJC|A Chain A, Crystal Structure Of The Pde5a Catalytic Domain In Complex With A Novel Inhibitor Length = 878 Back     alignment and structure
>pdb|3JWQ|A Chain A, Crystal Structure Of Chimeric Pde5/pde6 Catalytic Domain Complexed With Sildenafil Length = 330 Back     alignment and structure
>pdb|4DDL|A Chain A, Pde10a Crystal Structure Complexed With Novel Inhibitor Length = 338 Back     alignment and structure
>pdb|2WEY|A Chain A, Human Pde-Papaverine Complex Obtained By Ligand Soaking Of Cross-Linked Protein Crystals Length = 343 Back     alignment and structure
>pdb|3UI7|A Chain A, Discovery Of Orally Active Pyrazoloquinoline As A Potent Pde10 Inhibitor For The Management Of Schizophrenia Length = 333 Back     alignment and structure
>pdb|2Y0J|A Chain A, Triazoloquinazolines As A Novel Class Of Phosphodiesterase 10a (Pde10a) Inhibitors, Part 2, Lead-Optimisation. Length = 340 Back     alignment and structure
>pdb|4AEL|A Chain A, Pde10a In Complex With The Inhibitor Az5 Length = 344 Back     alignment and structure
>pdb|4HEU|A Chain A, Crystal Structure Of Pde10a With A Biaryl Ether Inhibitor ((1-(3-(4- ((1h-Benzo[d]imidazol-2-Yl)amino)phenoxy)pyridin-2- Yl)piperidin-4- Yl)methanol) Length = 318 Back     alignment and structure
>pdb|4DFF|A Chain A, The Sar Development Of Dihydroimidazoisoquinoline Derivatives As Phosphodiesterase 10a Inhibitors For The Treatment Of Schizophrenia Length = 352 Back     alignment and structure
>pdb|2OUN|A Chain A, Crystal Structure Of Pde10a2 In Complex With Amp Length = 331 Back     alignment and structure
>pdb|3SN7|A Chain A, Highly Potent, Selective, And Orally Active Phosphodiestarase 10a Inhibitors Length = 345 Back     alignment and structure
>pdb|2OUV|A Chain A, Crystal Structure Of Pde10a2 Mutant Of D564n Length = 331 Back     alignment and structure
>pdb|3UUO|A Chain A, The Discovery Of Potent, Selectivity, And Orally Bioavailable Pyrozoloquinolines As Pde10 Inhibitors For The Treatment Of Schizophrenia Length = 337 Back     alignment and structure
>pdb|3IBJ|A Chain A, X-Ray Structure Of Pde2a Length = 691 Back     alignment and structure
>pdb|3HQW|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 376 Back     alignment and structure
>pdb|3HQY|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 380 Back     alignment and structure
>pdb|2O8H|A Chain A, Crystal Structure Of The Catalytic Domain Of Rat Phosphodiesterase 10a Length = 362 Back     alignment and structure
>pdb|3LXG|A Chain A, Crystal Structure Of Rat Phosphodiesterase 10a In Complex Wi Web-3 Length = 308 Back     alignment and structure
>pdb|2OUR|A Chain A, Crystal Structure Of Pde10a2 Mutant D674a In Complex With Camp Length = 331 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query249
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 4e-73
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 6e-67
3v93_A345 Cyclic nucleotide specific phosphodiesterase; para 4e-64
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 6e-64
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 8e-64
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 1e-63
3hr1_A380 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 4e-63
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 5e-63
2our_A331 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 5e-63
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 5e-62
3dyn_A329 High affinity CGMP-specific 3',5'-cyclic phosphod 1e-61
3itu_A345 CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- 8e-61
1tbf_A347 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 4e-60
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 7e-60
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 8e-60
3qi3_A533 High affinity CGMP-specific 3',5'-cyclic phosphod 2e-59
2r8q_A359 Class I phosphodiesterase PDEB1; leishimaniasis, p 5e-57
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-04
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Length = 353 Back     alignment and structure
 Score =  225 bits (576), Expect = 4e-73
 Identities = 100/176 (56%), Positives = 130/176 (73%), Gaps = 1/176 (0%)

Query: 29  NTSVLENHHWRSAVGCLLESNVAEQL-GSIRPELEQQISSLILATDITRQQEFLTRFKAY 87
           NTSVLENHHWRSAVG L ES +   L    R ++E QI +LILATDI+RQ E+L+ F+++
Sbjct: 148 NTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSH 207

Query: 88  LDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNL 147
           LD G L L     RH +LQ+ALKCADI NPCR W++SK+WS+KV EEFF QGD E++ +L
Sbjct: 208 LDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHL 267

Query: 148 PVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWE 203
            V+ LCDRH+ SI  IQ GF  ++V PLF EW RF +T+LS +M+GH+  N+A W+
Sbjct: 268 GVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWK 323


>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Length = 349 Back     alignment and structure
>3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Length = 345 Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Length = 421 Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Length = 420 Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Length = 691 Back     alignment and structure
>3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Length = 380 Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Length = 377 Back     alignment and structure
>2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Length = 331 Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Length = 365 Back     alignment and structure
>3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 3n3z_A* Length = 329 Back     alignment and structure
>3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Length = 345 Back     alignment and structure
>1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Length = 347 Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} PDB: 3ecn_A* Length = 338 Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Length = 878 Back     alignment and structure
>3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Length = 533 Back     alignment and structure
>2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Length = 359 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query249
3dyn_A329 High affinity CGMP-specific 3',5'-cyclic phosphod 100.0
3itu_A345 CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- 100.0
3v93_A345 Cyclic nucleotide specific phosphodiesterase; para 100.0
2our_A331 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 100.0
3hr1_A380 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 100.0
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 100.0
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 100.0
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 100.0
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 100.0
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 100.0
1tbf_A347 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 100.0
3qi3_A533 High affinity CGMP-specific 3',5'-cyclic phosphod 100.0
2r8q_A359 Class I phosphodiesterase PDEB1; leishimaniasis, p 100.0
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 100.0
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 100.0
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 100.0
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 100.0
>3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 4gh6_A* 3n3z_A* Back     alignment and structure
Probab=100.00  E-value=4.1e-57  Score=415.02  Aligned_cols=192  Identities=32%  Similarity=0.527  Sum_probs=178.4

Q ss_pred             ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC--ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHHH
Q psy13496         14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES--NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKAY   87 (249)
Q Consensus        14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~--~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~~   87 (249)
                      +||.|++.   .||++|||+|||||||++++|.||+++  |++.+++ ..+..+|++||++||||||++||+++++|++.
T Consensus       122 ~nN~fli~t~s~LA~lYnd~SvLEnhH~a~~~~lL~~~~~nif~~l~~~~~~~~r~~ii~~ILATDm~~Hf~~l~~~~~~  201 (329)
T 3dyn_A          122 YNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEK  201 (329)
T ss_dssp             SCHHHHHHHTCHHHHHHTTSSHHHHHHHHHHHHHHTSGGGCTTTTSCHHHHHHHHHHHHHHHHHTCGGGHHHHHHHHHHH
T ss_pred             CCCHHHHHhCCHHHHHcCCCcHhHHHHHHHHHHHHhcccchhccCCCHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence            68888876   789999999999999999999999854  6777776 46788999999999999999999999999998


Q ss_pred             hhcCCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccchhhh
Q psy13496         88 LDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGF  167 (249)
Q Consensus        88 ~~~~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~QigF  167 (249)
                      ++  .+|+.++++|.++++++||||||||++|||+++++|+.++++|||.|||+|+++|+|++|+|||++..+|++|+||
T Consensus       202 ~~--~~~~~~~~~~~ll~~~lik~ADiSn~~rp~~v~~~W~~~l~eEFf~QgD~Ek~~glp~sp~~DR~~~~~~k~QigF  279 (329)
T 3dyn_A          202 ME--NFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGF  279 (329)
T ss_dssp             HT--TCCTTCHHHHHHHHHHHHHHHHTCGGGSCHHHHHHHHHHHHHHHHHHHHHHHHHTCCCCGGGCTTTCCHHHHHHHH
T ss_pred             Hh--hcccCCHHHHHHHHHHHHHHHhcccccCChHHHHHHHHHHHHHHHHhhhHHHhcCCCCCCCCCccccchhHHHHHH
Confidence            75  5788899999999999999999999999999999999999999999999999999999999999998999999999


Q ss_pred             HhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhh
Q psy13496        168 FKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKF  208 (249)
Q Consensus       168 i~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~  208 (249)
                      |++||.|+|+++++++|+ +.++++++|++|+++|+++.+.
T Consensus       280 i~~iv~Pl~~~l~~~~P~-~~~~~l~~L~~Nr~~w~~l~~~  319 (329)
T 3dyn_A          280 IKFVLIPMFETVTKLFPM-VEEIMLQPLWESRDRYEELKRI  319 (329)
T ss_dssp             HHHTHHHHHHHHHHHCTH-HHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHCHh-hHHHHHHHHHHHHHHHHHHHHH
Confidence            999999999999999997 6557999999999999998764



>3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Back     alignment and structure
>3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Back     alignment and structure
>2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Back     alignment and structure
>3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Back     alignment and structure
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} SCOP: a.211.1.0 PDB: 3ecn_A* Back     alignment and structure
>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Back     alignment and structure
>1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Back     alignment and structure
>3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Back     alignment and structure
>2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 249
d1so2a_415 a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phospho 2e-49
d1y2ka1326 a.211.1.2 (A:86-411) Catalytic domain of cyclic nu 2e-45
d1tbfa_326 a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphod 4e-45
d3dy8a1324 a.211.1.2 (A:182-505) High-affinity cGMP-specific 6e-45
d1taza_357 a.211.1.2 (A:) Catalytic domain of cyclic nucleoti 4e-43
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Length = 415 Back     information, alignment and structure

class: All alpha proteins
fold: HD-domain/PDEase-like
superfamily: HD-domain/PDEase-like
family: PDEase
domain: cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b
species: Human (Homo sapiens) [TaxId: 9606]
 Score =  165 bits (418), Expect = 2e-49
 Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 19/229 (8%)

Query: 29  NTSVLENHHWRSAVGCLLESNVAEQLGSIRPE----LEQQISSLILATDITRQQEFLTRF 84
           + SVLENHH  SA    L       L  +           +   ILATD+ +  +FL  F
Sbjct: 188 DRSVLENHHAASAWNLYLSRPEYNFLLHLDHVEFKRFRFLVIEAILATDLKKHFDFLAEF 247

Query: 85  KA---YLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDY 141
            A    ++S  ++ S   DR  + Q+ +K ADI+ P +  D+  KW++ +  EF+ QGD 
Sbjct: 248 NAKANDVNSNGIEWSNENDRLLVCQVCIKLADINGPAKVRDLHLKWTEGIVNEFYEQGDE 307

Query: 142 ERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAK 201
           E  L LP++   DR S  + K+Q  F   +V PL   +       L    +     N  +
Sbjct: 308 EANLGLPISPFMDRSSPQLAKLQESFITHIVGPLCNSYDAAGL--LPGQWLEAEEDNDTE 365

Query: 202 WEGFFKFVVSPLFEEWHRFLDT----------KLSTSMMGHLRGNQAKW 240
                        +E                 ++   +M HL  N   W
Sbjct: 366 SGDDEDGEELDTEDEEMENNLNPKPPRRKSRRRIFCQLMHHLTENHKIW 414


>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure
>d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure
>d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Length = 324 Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Length = 357 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query249
d1so2a_415 cGMP-inhibited 3',5'-cyclic phosphodiesterase B, p 100.0
d3dy8a1324 High-affinity cGMP-specific 3',5'-cyclic phosphodi 100.0
d1y2ka1326 Catalytic domain of cyclic nucleotide phosphodiest 100.0
d1tbfa_326 cGMP-specific 3',5'-cyclic phosphodiesterase pde5a 100.0
d1taza_357 Catalytic domain of cyclic nucleotide phosphodiest 100.0
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: All alpha proteins
fold: HD-domain/PDEase-like
superfamily: HD-domain/PDEase-like
family: PDEase
domain: cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b
species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00  E-value=1.8e-55  Score=413.03  Aligned_cols=226  Identities=27%  Similarity=0.384  Sum_probs=177.2

Q ss_pred             ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC---ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHH
Q psy13496         14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES---NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKA   86 (249)
Q Consensus        14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~---~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~   86 (249)
                      |+|.|++.   +||++|||+|||||||++++|+++.+.   +++.+++ ..+..+|++||++||||||++||+++++|+.
T Consensus       170 ~nN~Flv~t~~pLA~lYnd~SVLEnhH~a~a~~lll~~~~~nil~~l~~~e~~~~r~lii~~ILATDm~~Hf~~l~~f~~  249 (415)
T d1so2a_         170 RTNAFLVATNAPQAVLYNDRSVLENHHAASAWNLYLSRPEYNFLLHLDHVEFKRFRFLVIEAILATDLKKHFDFLAEFNA  249 (415)
T ss_dssp             CCHHHHHHTTCHHHHHTTTSSHHHHHHHHHHHHHHHTCGGGCTTTTSCHHHHHHHHHHHHHHHHTTCGGGHHHHHHHHHH
T ss_pred             ccHHHHHHcCCHHHHHhCCCCHHHHHHHHHHHHHHhcCcccchhhcCCHHHHHHHHHHHHHHHHccchhhHHHHHHHHHH
Confidence            89999987   689999999999999999999985433   5666666 4578899999999999999999999999998


Q ss_pred             Hhh---cCCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccc
Q psy13496         87 YLD---SGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKI  163 (249)
Q Consensus        87 ~~~---~~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~  163 (249)
                      +.+   .+++++.+++||.++++++|||||||||+|||+++.+|+.+|++|||.|||+|+++|+|++|+|||++.++|++
T Consensus       250 ~~~~~~~~~~~~~~~~~r~lv~~~lik~ADIs~~~rp~~v~~~W~~~l~~EF~~QGd~E~~lglp~sp~~DR~~~~~~k~  329 (415)
T d1so2a_         250 KANDVNSNGIEWSNENDRLLVCQVCIKLADINGPAKVRDLHLKWTEGIVNEFYEQGDEEANLGLPISPFMDRSSPQLAKL  329 (415)
T ss_dssp             HHTSSSCCCCCTTCHHHHHHHHHHHHHHHHTCGGGSCHHHHHHHHHHHHHHHHHHHHHHHHTTCCCCTTCCTTSCCHHHH
T ss_pred             HHHhhccCCcCCCCHHHHHHHHHHHHHHHhccCcccChHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccCcccccchHH
Confidence            864   46788999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhhHhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhhhcCcch-hhh---------Hhhhccccchhhhccc
Q psy13496        164 QTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLF-EEW---------HRFLDTKLSTSMMGHL  233 (249)
Q Consensus       164 QigFi~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~  233 (249)
                      |+|||++||+|||++++.+.+. . .++++++.+|+.+|++..+.+..+.. ++.         .+..+++.-...++++
T Consensus       330 QigFi~~iv~PLf~~l~~a~~~-~-~~~~~~~~~n~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  407 (415)
T d1so2a_         330 QESFITHIVGPLCNSYDAAGLL-P-GQWLEAEEDNDTESGDDEDGEELDTEDEEMENNLNPKPPRRKSRRRIFCQLMHHL  407 (415)
T ss_dssp             HHHHHHHTHHHHHHHHHHTTCS-C-CEECC-------------------------------------CCSSEECHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhhc-c-HHHHHHHHHHHHHHHHhHhhhhccchhhccccccccCCcchhhHHHHhhHHHHHH
Confidence            9999999999999999886543 1 35788999999999876554322211 111         1123444555788899


Q ss_pred             cccccccc
Q psy13496        234 RGNQAKWE  241 (249)
Q Consensus       234 ~~~~~~~~  241 (249)
                      .-|...|+
T Consensus       408 ~en~~~w~  415 (415)
T d1so2a_         408 TENHKIWK  415 (415)
T ss_dssp             HHHHHHHC
T ss_pred             HhhhhhcC
Confidence            99999996



>d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure